Concentration of rare earth elements, As, and Th in human brain and brain tumors, determined by neutron activation analysis.
about
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhoodRealizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma.In Vivo Uptake of Rare Earth Metals by Triple-Negative Breast Cancer Cells.Assessing the chemical behavior and spatial distribution of yttrium and rare earth elements (YREEs) in a coastal aquifer adjacent to the Urmia Hypersaline Lake, NW Iran.Occupation, exposure to chemicals and risk of gliomas and meningiomas in Sweden.Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.
P2860
Concentration of rare earth elements, As, and Th in human brain and brain tumors, determined by neutron activation analysis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Concentration of rare earth el ...... y neutron activation analysis.
@en
Concentration of rare earth el ...... y neutron activation analysis.
@nl
type
label
Concentration of rare earth el ...... y neutron activation analysis.
@en
Concentration of rare earth el ...... y neutron activation analysis.
@nl
prefLabel
Concentration of rare earth el ...... y neutron activation analysis.
@en
Concentration of rare earth el ...... y neutron activation analysis.
@nl
P2093
P356
P1476
Concentration of rare earth el ...... y neutron activation analysis.
@en
P2093
P2888
P356
10.1007/BF02784543
P577
1996-01-01T00:00:00Z
P6179
1044636303